12 results
F-3
EX-1.2
CMMB
Chemomab Therapeutics Ltd
16 Oct 23
Shelf registration (foreign)
4:25pm
, as amended, or any other applicable anti-bribery or anti-corruption law (collectively, “Anti-Corruption Laws”), (B) promised, offered, provided, attempted … or received or retained any funds in violation of any Anti-Corruption Laws.
(tt) Status Under the Securities Act. The Company is not an ineligible
8-K
EX-10.1
dilzqv 52a4meh
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
S-4
EX-2.1
2f5en
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
8-K
EX-2.1
q8klw
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
DEFA14A
EX-2.1
c3xekxe fdpiicm4
15 Dec 20
Additional proxy soliciting materials
3:32pm
6-K
EX-1.1
39x7d
14 Feb 19
Current report (foreign)
4:40pm
F-1/A
EX-1.1
brgwkk4 i3y3fk394r2
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
EX-1.1
rxchwxdlt5hqpn
31 Jan 19
Registration statement (foreign) (amended)
12:00am
- Prev
- 1
- Next